Literature DB >> 30802169

Reduction of Cardiovascular Mortality and Ischemic Events in Acute Medically Ill Patients.

Tarek Nafee1, C Michael Gibson1, Megan K Yee1, Mathieu Kerneis2, Yazan Daaboul2, Serge Korjian2, Gerald Chi2, Arzu Kalayci2, M Khurram Afzal2, Hassan Kazmi2, Sudarshana Datta2, Fahad AlKhalfan2, Adrian F Hernandez3, Russell D Hull4, Robert A Harrington5, Alexander T Cohen6, Samuel Z Goldhaber7.   

Abstract

Entities:  

Keywords:  acute disease; anticoagulants; factor Xa inhibitors; preventive care

Mesh：

Substances：

Year:  2019        PMID： 30802169     DOI： 10.1161/CIRCULATIONAHA.118.038654

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  4 in total

1.  Thromboembolism Prophylaxis for Patients Discharged From the Hospital: Easier Said Than Done.

Authors:  Samuel Z Goldhaber
Journal:  J Am Coll Cardiol       Date:  2020-06-30       Impact factor: 24.094

2.  Benefit-Risk of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness: Pooled Analysis From MAGELLAN and MARINER.

Authors:  Gary E Raskob; Alex C Spyropoulos; Theodore E Spiro; Wentao Lu; Zhong Yuan; Bennett Levitan; Eunyoung Suh; Elliot S Barnathan
Journal:  J Am Heart Assoc       Date:  2021-11-10       Impact factor: 5.501

3.  Sex-, Race- and Ethnicity-Based Differences in Thromboembolic Events Among Adults Hospitalized With COVID-19.

Authors:  Sadia Ilyas; Stanislav Henkin; Pablo Martinez-Camblor; Bjoern D Suckow; Jocelyn M Beach; David H Stone; Philip P Goodney; Joseph E Ebinger; Mark A Creager; Jesse A Columbo
Journal:  J Am Heart Assoc       Date:  2021-11-30       Impact factor: 5.501

Review 4.  Current Opinion on the use of Direct Oral Anticoagulants for the Prophylaxis of Venous Thromboembolism among Medical Inpatients.

Authors:  Jane J Lee; Sahar Memar Montazerin; Fahimehalsadat Shojaei; Gerald Chi
Journal:  Ther Clin Risk Manag       Date:  2021-05-26       Impact factor: 2.423
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.